• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1012463-28
Device Problems Peeled/Delaminated (1454); Failure to Advance (2524)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/17/2014
Event Type  malfunction  
Event Description
It was reported that the procedure was to treat a lesion in the left circumflex (lcx) artery, with heavy tortuosity and mild calcification.Pre-dilatation was performed with a 2.5 x 12mm non-compliant (nc) balloon at 16 and 18 atmospheres, reducing the stenosis to less than 40%.The 3.0 x 28 mm device was advanced, but could not cross due to the anatomy.A xience xpedition was used to successfully complete the procedure.There was no reported clinically significant delay due to the failure to cross.There was no adverse patient effect.No additional information was provided.Returned device analysis on (b)(4) 2014 observed material peeling on the balloon.
 
Manufacturer Narrative
(b)(4).Though the device is not approved for sale in the u.S., it uses a delivery system which is similar to a device sold in the u.S.Evaluation summary: the device was returned for evaluation.The failure to advance could not be replicated in a testing environment as it was based on operational circumstances.Balloon shredding/peeling was observed, which was likely caused by the interaction with the tortuosity and calcification.Based on visual and dimensional analysis of the returned device, there is no indication of a product deficiency.A review of the lot history record revealed no non-conformances that would have contributed to this complaint.A query/review of the complaint history of the reported lot did not indicate a manufacturing issue.Based on the information reviewed, there is no indication of a product deficiency.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key3873257
MDR Text Key4570352
Report Number2024168-2014-03848
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P070015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 04/19/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/27/2014
Device Catalogue Number1012463-28
Device Lot Number3102861
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/20/2014
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/22/2014
Initial Date FDA Received06/13/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age49 YR
Patient Weight60
-
-